Kandaswami C, Perkins E, Soloniuk D S, Drzewiecki G, Middleton E
Department of Medicine, State University of New York, School of Medicine and Biomedical Sciences, Buffalo 14203.
Anticancer Drugs. 1993 Feb;4(1):91-6. doi: 10.1097/00001813-199302000-00012.
We examined the effects of flavone and two polyhydroxylated plant flavonoids (quercetin and fisetin), either singly or in combination with ascorbic acid, on the growth of a human squamous cell carcinoma cell line (HTB 43) in vitro. Fisetin and quercetin significantly impaired cell growth in the presence of ascorbic acid. Exposure of cells to ascorbic acid (2 micrograms/ml) and 2 micrograms/ml of either fisetin or quercetin resulted in 61 and 45% inhibition of cell growth, respectively, in 72 h, while treatment with ascorbic acid alone had no effect on cellular proliferation. Flavone and ascorbic acid, either as single agents or in combination, exhibited no significant inhibition at any of the concentrations tested. The enhancement of the antiproliferative effect of the above flavonoids by ascorbic acid may be due to its ability to protect these compounds against oxidative degradation.
我们研究了黄酮以及两种多羟基植物黄酮(槲皮素和漆黄素)单独或与抗坏血酸联合使用时,对人鳞状细胞癌细胞系(HTB 43)体外生长的影响。在抗坏血酸存在的情况下,漆黄素和槲皮素显著抑制细胞生长。将细胞暴露于抗坏血酸(2微克/毫升)以及2微克/毫升的漆黄素或槲皮素中,72小时后细胞生长分别受到61%和45%的抑制,而单独使用抗坏血酸处理对细胞增殖没有影响。黄酮和抗坏血酸单独或联合使用时,在所测试的任何浓度下均未表现出显著抑制作用。抗坏血酸增强上述黄酮类化合物的抗增殖作用,可能是由于其能够保护这些化合物免受氧化降解。